Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01303562 · ClinicalTrials.gov registry record · NA
Clinical Assessment of Barley and Oat Phytochemicals
A NA study, sponsored by Tufts University.
- Completed
- Registry status
- NA
- Development phase
- 13
- Enrollment target
NCT01303562 is a NA study that has completed, run by Tufts University. The registered enrollment target is 13 participants.
The verdict
NCT01303562, a NA study, has completed, sponsored by Tufts University.
- COMPLETED
- Registry status
- NA
- Development phase
- 13 participants
- Enrollment target
Study Summary
The goal of this placebo-controlled, 3-way crossover study is to determine the acute (24-h) bioavailability and pharmacokinetics of the major phytochemicals found whole barley and oats, as well as their effects on selected measures of antioxidation, inflammation, insulin sensitivity/glucose regulation, and vascular remodeling following challenge by an oral glucose tolerance test (OGTT).
Interventions
- OTHER Whole grain oats and barley
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2010-09 |
| Est. Completion | 2013-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01303562
The ClinicalTrials.gov registry entry for NCT01303562 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 13 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Tufts University, which has 163 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Whole grain oats and barley is the first listed.
NCT01303562 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01303562 about?
NCT01303562 is a clinical study titled "Clinical Assessment of Barley and Oat Phytochemicals". The goal of this placebo-controlled, 3-way crossover study is to determine the acute (24-h) bioavailability and pharmacokinetics of the major phytochemicals found whole barley and oats, as well as their effects on selected measures of antioxidation, inflammation, insulin sensitivity/glucose regulati...
What is the current status of trial NCT01303562?
This trial is currently completed. It is a NA study. The enrollment target is 13 participants. The study started on 2010-09. Estimated completion is 2013-02.
What interventions are being tested in trial NCT01303562?
The interventions under investigation include: Whole grain oats and barley (OTHER).
Who is sponsoring clinical trial NCT01303562?
This trial is sponsored by Tufts University, which has 163 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.